文献速递肝病

四种CD8阳性淋巴细胞活化标志物预测儿童急性肝衰竭临床结局

Four Biomarkers Linked to Activation of Cluster of Differentiation 8-Positive Lymphocytes Predict Clinical Outcomes in Pediatric Acute Liver Failure.
PubMed 文献 · Hepatology · 2021-01-01

在47例儿童急性肝衰竭(PALF)参与者中,用4种免疫活化标志物(IAM)划分高、中、低IAM组;高IAM组 indeterminate 病因更多、峰值胆红素更高、21天肝移植率更高(62.5% vs 28.2% vs 4.8%,P=0.002),独立验证队列(n=71)趋势相似但未达统计学显著。

要点

  • 4种IAM可区分PALF免疫活化亚型,高IAM组肝移植更频繁。
  • 高IAM与 indeterminate 病因、更高峰值胆红素和昏迷等级相关。
  • 基线高转氨酶、高胆红素和白细胞减少预测高免疫活化。

核心结论

  • 四种循环T淋巴细胞活化标志物识别出具有免疫活化证据的PALF亚组,该亚组有独特临床表型和更高肝移植率。

研究设计与样本

  • 在47例PALF研究参与者中,入组后≤6天采集12种IAM,用流式细胞术和IMMULITE法检测血NK和CD8+淋巴细胞,并行无监督层次分析。

主要发现

  • 高IAM组中 indeterminate 病因占比高于明确诊断组(80% vs 20%,P<0.001)。
  • 高IAM组峰值血清总胆红素中位数高于低IAM组(21.7 vs 4.8 mg/dL,P<0.001),峰值昏迷等级也更高。
  • 21天结局组间不同,高IAM组肝移植率62.5%,中IAM组28.2%,低IAM组4.8%(P=0.002);未报告死亡。
  • 独立验证队列(n=71)中IAM组按病因、初始生化和短期结局的分离趋势相似,但未达统计学显著。
  • 研究入组时高血清转氨酶、总胆红素水平和白细胞减少预测高免疫活化特征。

关键数值与推荐

  • 推导队列用4种IAM(穿孔素阳性CD8细胞百分比、颗粒酶阳性CD8细胞百分比、CD8细胞绝对数、可溶性白介素-2受体水平)定义高IAM(n=10)、中IAM(n=15)和低IAM(n=22)组。

临床怎么用

  • 这些生物标志物可能识别适合未来早期靶向免疫抑制临床试验的PALF参与者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Immune dysregulation contributes to the pathogenesis of pediatric acute liver failure (PALF). Our aim was to identify immune activation markers (IAMs) in PALF that are associated with a distinct clinical phenotype and outcome. APPROACH AND RESULTS: Among 47 PALF study participants, 12 IAMs collected ≤6 days after enrollment were measured by flow cytometry and IMMULITE assay on blood natural killer and cluster of differentiation 8-positive (CD8+ ) lymphocytes and subjected to unsupervised hierarchical analyses. A derivation cohort using 4 of 12 IAMs which were available in all participants (percent perforin-positive and percent granzyme-positive CD8 cells, absolute number of CD8 cells, soluble interleukin-2 receptor level) were sufficient to define high (n = 10), medium (n = 15), and low IAM (n = 22) cohorts. High IAM was more frequent among those with indeterminate etiology than those with defined diagnoses (80% versus 20%, P < 0.001). High IAM was associated with higher peak serum total bilirubin levels than low IAM (median peak 21.7 versus 4.8 mg/dL, P < 0.001) and peak coma grades. The 21-day outcomes differed between groups, with liver transplantation more frequent in high IAM participants (62.5%) than those with medium (28.2%) or low IAM (4.8%) (P = 0.002); no deaths were reported. In an independent validation cohort (n = 71) enrolled in a prior study, segregation of IAM groups by etiology, initial biochemistries, and short-term outcomes was similar, although not statistically significant. High serum aminotransferases, total bilirubin levels, and leukopenia at study entry predicted a high immune activation profile. CONCLUSION: Four circulating T-lymphocyte activation markers identify a subgroup of PALF participants with evidence of immune activation associated with a distinct clinical phenotype and liver transplantation; these biomarkers may identify PALF participants eligible for future clinical trials of early targeted immunosuppression.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Leonis MA, Miethke AG, Fei L, et al. Four Biomarkers Linked to Activation of Cluster of Differentiation 8-Positive Lymphocytes Predict Clinical Outcomes in Pediatric Acute Liver Failure. Hepatology. 2021. PMID: 32294261. doi:10.1002/hep.31271

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。